跳至主要内容
临床试验/NCT06250985
NCT06250985招募中3 期

New Treatment of Cardiovascular Implantable Electronic Device (CIED) Infections; Immediate Reimplantation After Removal of Infected System

Rigshospitalet, Denmark2 个研究点 分布在 1 个国家目标入组 176 人开始时间: 2024年4月29日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
176
试验地点
2
主要终点
Composite primary outcome

研究概览

简要总结

The goal of this randomized clinical trials is to ascertain the safety and efficacy of immediate reimplantation of cardiac electronic implantable devices in patients with endocarditis and device-infections, compared to standard care, i.e. reimplantation at a later procedure date.

The primary outcome is the occurence of the composite primary endpoint within 6 months of randomization consisting of

  • Death
  • Symptomatic embolism (systemic arterial embolism or pulmonary embolism)
  • Bacteremia og pocket-infection
  • Removal of a CIED due to new infection

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 110 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Culture positive or negative infection of a CIED acording to PI
  • Indication for removal of device
  • Clinical indication of device removal of existing device (concurrent left-sided IE is not a contraindication).
  • Indication for reimplantation of new device
  • A minimum of 3 days of sufficient antibiotic treatment (intravenous or oral) has been administered and/or culture negative antibiotic regimen have been adminstered until blood culture is examined.
  • stabilization criteria fulfilled i.e. I) negativ blood cultures, II) WBC < 15 mia/L or reduction of min. 25% and III) CRP <50 or min. 25% reduction.

排除标准

  • Immunoincompetence (active chemotherapy or prednisone treatment > 20mg/day
  • Device-infection within last 6 months (relaps)
  • Septic shock
  • Stabilization criteria not fulfilled after 10 days of suficient antibiotic treatment

结局指标

主要结局

Composite primary outcome

时间窗: within 6 months of randomization

Composite endpoint consisting of number of participants with one or more of the following events during follow-up: death, symptomatic embolism (systemic or pulmonary), bacteremia or pocket infection with same bacterial pathogen or removal of device due to new infection.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Henning Bundgaard

Professor

Rigshospitalet, Denmark

研究点 (2)

Loading locations...

相似试验